Two Ulcerative Colitis Biologics: Same Clinical Difference?

(MedPage Today) -- While infliximab (Remicade) and vedolizumab (Entyvio) were comparable for clinical remission in previously biologic-naive ulcerative colitis patients, infliximab was more likely to result in corticosteroid-free clinical remission...